ONCOMETHYLOME SCIENCES RECEIVES ISO 9001:2008 CERTIFICATION
(Thomson Reuters ONE) -
DURHAM, NC, and LIEGE, BELGIUM - May 27, 2010,10:00 CET - OncoMethylome Sciences
(Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular
diagnostics company, announced today that its Belgium based clinical diagnostics
service laboratory has received the important ISO 9001:2008 certification from
Lloyds Register Quality Assurance Ltd.
ISO's internationally recognized standard confirms that Oncomethylome Sciences'
Quality Management System consistently meets customer and regulatory
requirements for research, design, assay development and clinical molecular
diagnostic service testing.
"The ISO certification for our quality management system constitutes an
essential validation of OncoMethylome's pharmaceutical and clinical diagnostic
business activities and demonstrates our commitment to develop the highest
quality products and services for our customers," said Dr. Jan Groen, President
and Chief Executive Officer of OncoMethylome.
About OncoMethylome Sciences
OncoMethylome Sciences SA is a leading molecular diagnostics company that
commercializes and develops cancer-screening tests to assist physicians in
detecting and treating cancer early. The company's tests are based on
proprietary gene methylation technology invented at Johns Hopkins University and
are designed to help the physician accurately detect early stages of cancer
development, predict a patient's response to drug therapy, and predict the
likelihood of cancer recurrence. OncoMethylome Sciences collaborates with
leading cancer research centers such as Johns Hopkins, in Baltimore, MD, and has
a number of commercial and collaborative partnerships with LabCorp,
Schering-Plough, GlaxoSmithKline Biologicals, Roche, Millipore Corporation's
BioScience Division, Merck KGaA and Qiagen.
For more information:
Dr. Jan Groen
CEO
+32 4.364.20.70 office
IR(at)oncomethylome.com
This press release contains forward-looking statements and estimates with
respect to the anticipated future performance of OncoMethylome and the market in
which it operates. Such statements and estimates are based on assumptions and
assessments of known and unknown risks, uncertainties and other factors, which
were deemed reasonable but may not prove to be correct. Actual events are
difficult to predict, may depend upon factors that are beyond the Company's
control, and may turn out to be materially different.
[HUG#1419171]
2010-5-27 ISO ENG: http://hugin.info/137314/R/1419171/369295.pdf
Unternehmensinformation / Kurzprofil:
Datum: 27.05.2010 - 10:01 Uhr
Sprache: Deutsch
News-ID 21551
Anzahl Zeichen: 0
contact information:
Town:
Liège
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 536 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ONCOMETHYLOME SCIENCES RECEIVES ISO 9001:2008 CERTIFICATION"
steht unter der journalistisch-redaktionellen Verantwortung von
OncoMethylome Sciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
